Ana M. Ramos‐Leví

Immune-related adverse events predict the therapeutic efficacy of anti–PD-1 antibodies in cancer patients

Jacobo Rogado, J.M. Sánchez-Torres, Nuria Romero-Laorden et al. · European Journal of Cancer · 2019 · 261 citations

Life Sciences, Immunology, Oncology +17

Single-anastomosis duodenoileal bypass with sleeve gastrectomy (SADI-S) for obese diabetic patients

Andrés Sánchez-Pernaute, Miguel A. Rubio, Lucio Cabrerizo et al. · Surgery for Obesity and Related Diseases · 2015 · 171 citations

Medicine, Endocrinology, Surgery +11

Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders

Marlen Vitales‐Noyola, Ana M. Ramos‐Leví, Rebeca Martínez‐Hernández et al. · Endocrine · 2017 · 69 citations

Life Sciences, Endocrinology, Immunology +16

Levels of regulatory T cells CD69+NKG2D+IL-10+ are increased in patients with autoimmune thyroid disorders

Ana Rodríguez‐Muñoz, Marlen Vitales‐Noyola, Ana M. Ramos‐Leví et al. · Endocrine · 2015 · 66 citations

Life Sciences, Endocrinology, Immunology +14

A MicroRNA Signature for Evaluation of Risk and Severity of Autoimmune Thyroid Diseases

Rebeca Martínez‐Hernández, Miguel Sampedro‐Núñez, Ana Serrano-Somavilla et al. · The Journal of Clinical Endocrinology & Metabolism · 2018 · 56 citations · Full text

Life Sciences, Endocrinology, Molecular Biology +12